Clinical Trials Logo

Clinical Trial Summary

Benign Prostatic Hyperplasia (BPH) affects the storage and voiding phases of the micturition cycle. Lower urinary tract symptoms (LUTS) refers to storage symptoms such as urinary frequency, urgency, urge urinary incontinence and nocturia. Surgical options for bladder outlet obstruction (BOO), including prostate ablation and transurethral resection, are currently offered for symptomatic improvement. However, 30% of patients report persistent LUTS after BOO procedures. Neuroplasticity induced by BPH and BOO can be contributory of persistent LUTS in these men, having different brain activation patterns during the micturition cycle. The investigators proposed unique multimodal functional Magnetic Resonance Imaging (fMRI) study that will identify for the first time, structural and functional brain contributions to LUTS in men with BPH and BOO at baseline and following BOO procedures. The investigators hypothesize that men with symptomatic BPH who have persistent LUTS following BOO procedures have a distinct brain activation pattern in Regions of Interest (RoI) that regulate the micturition cycle.


Clinical Trial Description

The investigators propose a unique, multimodal prospective study that will allow investigators to identify for the first time the structural and functional brain contributions to LUTS in men with BPH and BOO at baseline and post procedure. For this, The investigators will recruit three different groups of patients: Group 1: Patients with BPH and significant improvement in the storage symptoms following BOO procedures. Group 2: Patients with BPH who have persistent storage symptoms following BOO procedures. Group 3 (CONTROL GROUP): Men without LUTS who are planning to undergo radical prostatectomy. Each participant will provide a detailed history, undergo a complete physical examination and will have the following assessments: IPSS, IPSS Quality of life, Incontinence Severity Index (ISI), Patient Global impression of severity (PGI-S) and improvement (PGI-I)19, 20, International Index of Erectile Function (IIEF-5), MRI Safety Screening Questionnaire. A post void residual volume will be measured and a urine sample will be obtained for urinalysis (patients and controls). A two-day bladder diary will also be obtained from the participants. Participants in group 1 and 2 will undergo a clinical urodynamic study within a year prior to the neuroimaging scan. All participants will be followed up at one, three and six months after the BOO procedures (Transurethral resection/ablation of prostate and simple prostatectomy) and radical prostatectomy in the control group. On each visit, the investigators will gather the following data: Uroflow and PVR assessment, bladder diary, and all questionnaires will be repeated in all patients at one, three, and six months. Participants with persistent storage LUTS at six months will have a repeat UDS to ensure BOO is resolved. Group 1 and 2 will undergo simultaneous fMRI/UDS scanning twice during this study: First before BOO procedures and at the second one at six months. The control group will undergo baseline fMRI/UDS. Investigators' established platform for simultaneous urodynamic study and functional MRI scanning will allow investigators to detect structural changes during the micturition cycle. Providing 3D structural images and functional images to have a better understanding of the brain effect on LUTS. By correlating the bold signal changes, structural markers and participant's clinical data, investigators will provide scientific rationale for subsequent studies in the field of neurourology. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03991429
Study type Observational
Source The Methodist Hospital Research Institute
Contact
Status Completed
Phase
Start date June 4, 2019
Completion date July 31, 2022

See also
  Status Clinical Trial Phase
Active, not recruiting NCT04010656 - Optimization of Spontaneous Postoperative Trial of Void Among Women N/A
Enrolling by invitation NCT05537272 - The Efficacy of Tamsulosin and Tadalafil Compared to Placebo in the Treatment and Prevention of Urinary Disorders After Transperineal Prostate Biopsy Phase 4
Recruiting NCT06070675 - Comparison of a Paper and Automated Bladder Diary in Pediatric Patients N/A
Completed NCT03141372 - Urinary Retention After Total Laparoscopic Hysterectomy With Immediate Foley Catheter Removal Versus Backfill Void Trial N/A
Completed NCT03373773 - Home vs. Office Foley Catheter Removal in Women With Voiding Difficulty Following Pelvic Reconstructive Surgery N/A
Recruiting NCT05490082 - Mirabegron, Propevirine, Solifenacin for Treatment of Lower Urinary Tract Symptoms During Intravesical BCG Instillation Phase 3
Recruiting NCT04429360 - What is the Effect of Prolapse Surgery on Voiding?
Completed NCT05182853 - Voiding Disorders in Children After Sacrococcygeal Teratoma Resection
Completed NCT05941260 - Standardization of Prostatic Resection by Virtual Computational Reconstruction and Computational Flow Dynamics
Completed NCT03390790 - Lidocaine for Pain After Urodynamic Testing Phase 4
Completed NCT04928716 - Multiple Sclerosis and Voiding Symptoms: How to Assess?
Completed NCT04064619 - Compare Sudden Stopping and Weaning of Anticholinergics in Recurrence of OAB Symptoms N/A
Not yet recruiting NCT05240456 - Beta 3 Agonists in Treatment of Non-neurogenic Voiding Dysfunction in Children Phase 1/Phase 2
Recruiting NCT03293771 - Transgender Post-reassignment Urogynecologic Measures and Perceptions
Completed NCT03631160 - Effect of Transcutaneous Acupoint Electrical Stimulation on Postoperative Spontaneous Voiding for Laparoscopic Patients N/A
Completed NCT05295823 - Patient Self Measurement of Post-Void Residual Bladder Volume (PVR) Using Ultrasound N/A
Completed NCT04570605 - Feasibility of Parasacral Transcutaneous Electrical Nerve Stimulation PTENS for Voiding Dysfunction in Peds Population N/A
Completed NCT04184752 - Prevalence of Detrusor Underactivity and Bladder Outlet Obstruction in Female Without Cystocele